CLOPIBEST

This brand name is authorized in Nigeria.

Active ingredients

The drug CLOPIBEST contains one active pharmaceutical ingredient (API):

1	Clopidogrel UNII 08I79HTP27 - CLOPIDOGREL BISULFATE
	Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation.
	Read more about Clopidogrel

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101162	Tablet	Clopibest Tablets 75 mg TAB 75 mg 3 x 10's (in Alu-Alu blisters)	Oral tablet Peach colored, round shaped, deep convex, plain on both the sides of film coated tablets NF-PP-344743 Clopibest Tablets 75 mg Clopidogrel Tablets USP 75 mg Active: Clopidogrel Tablets USP 75 mg; Excipients: Microcelac 100, Low substituted Hydroxypropyl Cellulose, Hydrogentaed castor oil, Instacoat Aqua-III 聽 Drugs Imported Products 310 Prescription Only Medicine (POM) 12/7/2023 GENERICS AND SPECIALITIES LIMITED, 9 Dave Anazodo Street, Ajao Estate, Isolo, Lagos 8033344839 cyril@gslnigeria.com Lincoln Pharmaceutials Ltd, Trimul Estate, AT & Post Khatraj, Tal Kalol, Dist. Gandhinagar, Gujarat, India, India	30/01/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC04	Clopidogrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101162